Application of autologous cells is considered for a broad range of regenerative therapies because it is not surrounded by the immunological and ethical issues of allo- or xenogenic cells. However, isolation, expansion, and application of autologous cells do suffer from variability in therapeutic efficacy due to donor to donor differences and due to prolonged culture. One important source of autologous cells is mesenchymal stromal cells (MSCs), which can differentiate toward endothelial-like cells, thus making them an ideal candidate as cell source for tissue vascularization. Here we screened MSCs from 20 donors for their endothelial differentiation capacity and correlated it with the gene expression profile of the whole genome in the undifferentiated state. Cells of all donors were able to form tubes on Matrigel and induced the expression of endothelial genes, although with quantitative differences. In addition, we analyzed the effect of prolonged in vitro expansion on the multipotency of human MSCs and found that endothelial differentiation is only mildly sensitive to expansion-induced loss of differentiation as compared to osteogenic and adipogenic differentiation. Our results show the robustness of the endothelial differentiation protocol and the gene expression data give insight in the differences in endothelial differentiation between donors.
Get full access to this article
View all access options for this article.
References
1.
SiddappaR., LichtR., van BlitterswijkC., de BoerJ.Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res, 25:1029. 2007.
OreffoR.O., BennettA., CarrA.J., TriffittJ.T.Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand J Rheumatol, 27:415. 1998.
4.
D'IppolitoG., SchillerP.C., RicordiC., RoosB.A., HowardG.A.Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res, 14:1115. 1999.
Sanchez-RamosJ., SongS., Cardozo-PelaezF., HazziC., StedefordT.et al.Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol, 164:247. 2000.
10.
Janeczek PortalskaK., LeferinkA., GroenN., FernandesH., MoroniL., van BlitterswijkC., de BoerJ.Endothelial differentiation of mesenchymal stromal cells. Plos One, 7:e46842. 2012.
11.
OswaldJ., BoxbergerS., JorgensenB., FeldmannS., EhningerG.et al.Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells, 22:377. 2004.
12.
LiuJ.W., Dunoyer-GeindreS., Serre-BeinierV., MaiG., LambertJ.F.et al.Characterization of endothelial-like cells derived from human mesenchymal stem cells. J Thromb Haemost, 5:826. 2007.
13.
RouwkemaJ., RivronN.C., BettahalliN.M.S., StamatialisD., WesslingM.et al.Mesenchymal stem cells differentiate towards endothelial cells in a prevascularized bone tissue engineering setting. Tissue Eng A, 14:756. 2008.
14.
CaoY., SunZ., LiaoL., MengY., HanQ.et al.Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo. Biochem Biophys Res Commun, 332:370. 2005.
15.
FischerL.J., McIlhennyS., TulenkoT., GolesorkhiN., ZhangP.et al.Endothelial differentiation of adipose-derived stem cells: effects of endothelial cell growth supplement and shear force. J Surg Res, 152:157. 2009.
SilvaG.V., LitovskyS., AssadJ.A., SousaA.L., MartinB.J.et al.Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation, 111:150. 2005.
18.
FennemaE.M., RenardA.J., LeusinkA., van BlitterswijkC.A., de BoerJ.The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta Orthop, 80:618. 2009.
19.
HornP., BokermannG., CholewaD., BorkS., WalendaT.et al.Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy, 12:888. 2010.
20.
SiddappaR., FernandesH., LiuJ., van BlitterswijkC., de BoerJ.The response of human mesenchymal stem cells to osteogenic signals and its impact on bone tissue engineering. Curr Stem Cell Res Ther, 2:209. 2007.
21.
PhinneyD.G., KopenG., RighterW., WebsterS., TremainN.et al.Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem, 75:424. 1999.
22.
MendesS.C., TibbeJ.M., VeenhofM., BakkerK., BothS.et al.Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tissue Eng, 8:911. 2002.
23.
AlvesH., van GinkelJ., GroenN., HulsmanM., MentinkA.et al.A mesenchymal stromal cell gene signature for donor age. PLoS One, 7:e42908. 2012.
24.
QuiriciN., SoligoD., BossolascoP., ServidaF., LuminiC.et al.Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol, 30:783. 2002.
25.
OyajobiB.O., LomriA., HottM., MariePJ. Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO-1 monoclonal antibody. J Bone Miner Res, 14:351. 1999.
26.
Dell'AccioF., De BariC., LuytenF.P.Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum, 44:1608. 2001.
KassemM., AnkersenL., EriksenE.F., ClarkB.F., RattanS.I.Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporos Int, 7:514. 1997.
29.
KveiborgM., KassemM., LangdahlB., EriksenE.F., ClarkB.F.et al.Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients. Mech Ageing Dev, 106:261. 1999.
30.
WagnerW., HornP., CastoldiM., DiehlmannA., BorkS.et al.Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One, 3:e2213. 2008.
31.
BothS.K., van der MuijsenbergA.J., van BlitterswijkC.A., de BoerJ., de BruijnJ.D.A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng, 13:3. 2007.
32.
FernandesH., MentinkA., BankR., StoopR., van BlitterswijkC.et al.Endogenous collagen influences differentiation of human multipotent mesenchymal stromal cells. Tissue Eng Part A, 16:1693. 2010.
33.
LivakK.J., SchmittgenT.D.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25:402. 2001.
34.
WettenhallJ.M., SmythG.K.limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics (Oxford, England), 20:3705. 2004.
35.
DominiciM., Le BlancK., MuellerI., Slaper-CortenbachI., MariniF.et al.Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315. 2006.
36.
XuW., ZhangX., QianH., ZhuW., SunX.et al.Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood), 229:623. 2004.
37.
RastegarF., ShenaqD., HuangJ., ZhangW., ZhangB.Q.et al.Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells, 2:67. 2010.
38.
BiancoP., CaoX., FrenetteP.S., MaoJ.J., RobeyP.G.et al.The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med, 19:35. 2013.
39.
KasperG., MaoL., GeisslerS., DraychevaA., TrippensJ.et al.Insights into mesenchymal stem cell aging: involvement of antioxidant defense and actin cytoskeleton. Stem Cells, 27:1288. 2009.
IngramD.A., MeadL.E., TanakaH., MeadeV., FenoglioA.et al.Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood, 104:2752. 2004.
42.
LevenbergS., GolubJ.S., AmitM., Itskovitz-EldorJ., LangerR.Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A, 99:4391. 2002.
43.
JinE., LiuJ., SuehiroJ., YuanL., OkadaY.et al.Differential roles for ETS, CREB, and EGR binding sites in mediating VEGF receptor 1 expression in vivo. Blood, 114:5557. 2009.
44.
SuehiroJ., HamakuboT., KodamaT., AirdW.C., MinamiT.Vascular endothelial growth factor activation of endothelial cells is mediated by early growth response-3. Blood, 115:2520. 2010.
45.
RuanQ., HanS., JiangW.G., BoultonM.E., ChenZ.J.et al.alphaB-crystallin, an effector of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells. Mol Cancer Res, 9:1632. 2011.
46.
Al-RawiM.A., WatkinsG., ManselR.E., JiangW.G.The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol, 27:721. 2005.
47.
MingJ., ZhangQ., QiuX., WangE.Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. Eur J Cancer, 45:866. 2009.
48.
WuG., HaynesT.E., YanW., MeiningerC.J.Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine. Diabetologia, 44:196. 2001.
49.
MurthiP., HidenU., RajaramanG., LiuH., BorgA.J.et al.Novel homeobox genes are differentially expressed in placental microvascular endothelial cells compared with macrovascular cells. Placenta, 29:624. 2008.
50.
DusD., KrawczenkoA., ZaleckiP., PaprockaM., WiedlochaA.et al.IL-7 receptor is present on human microvascular endothelial cells. Immunol Lett, 86:163. 2003.
51.
AlvesH., Munoz-NajarU., De WitJ., RenardA.J., HoeijmakersJ.H.et al.A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells. J Cell Mol Med, 14:2729. 2010.
52.
GrawJ.Genetics of crystallins: cataract and beyond. Exp Eye Res, 88:173. 2009.
53.
PickensS.R., ChamberlainN.D., VolinM.V., PopeR.M., TalaricoN.E.et al.Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum, 63:2884. 2011.
54.
MingJ., JiangG., ZhangQ., QiuX., WangE.Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer. Cancer Immunol Immunother, 61:79. 2012.
55.
NerlichA.G., SauerU., Kolm-LittyV., WagnerE., KochM.et al.Expression of glutamine:fructose-6-phosphate amidotransferase in human tissues: evidence for high variability and distinct regulation in diabetes. Diabetes, 47:170. 1998.
56.
CrowleyM.A., ConlinL.K., ZackaiE.H., DeardorffM.A., ThielB.D.et al.Further evidence for the possible role of MEIS2 in the development of cleft palate, cardiac septum. Am J Med Genet A, 152A:1326. 2010.
57.
KhuranaA., LiuP., MelloneP., LorenzonL., VincenziB.et al.HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells. Cancer Res, 71:2152. 2011.
58.
HanC.H., HuangY.J., LuK.H., LiuZ., MillsG.B.et al.Polymorphisms in the SULF1 gene are associated with early age of onset and survival of ovarian cancer. J Exp Clin Cancer Res, 30:5. 2011.
59.
YangJ.D., SunZ., HuC., LaiJ., DoveR.et al.Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival. Genes Chromosomes Cancer, 50:122. 2011.
60.
LapucciA., LulliM., AmedeiA., PapucciL., WitortE.et al.zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia. FASEB J, 24:1852. 2010.
61.
BattkeC., KremmerE., MysliwietzJ., GondiG., DumitruC.et al.Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol Immunother, 60:649. 2011.
62.
HsiehM.J., ChenK.S., ChiouH.L., HsiehY.S.Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. Eur J Cell Biol, 89:598. 2010.
63.
OksalaN., LevulaM., Pelto-HuikkoM., KytomakiL., SoiniJ.T.et al.Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study. Ann Med, 42:360. 2010.
SakthianandeswarenA., ChristieM., D'AndretiC., TsuiC., JorissenR.N.et al.PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res, 71:3709. 2011.
66.
HossainG.S., van ThienenJ.V., WerstuckG.H., ZhouJ., SoodS.K.et al.TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia. J Biol Chem, 278:30317. 2003.
67.
CurranM.E., AtkinsonD.L., EwartA.K., MorrisC.A., LeppertM.F.et al.The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell, 73:159. 1993.
68.
CliffordP.S., EllaS.R., StupicaA.J., NourianZ., LiM.et al.Spatial distribution and mechanical function of elastin in resistance arteries: a role in bearing longitudinal stress. Arterioscler Thromb Vasc Biol, 31:2889. 2011.
69.
DaiZ., ChungS.K., MiaoD., LauK.S., ChanA.W.et al.Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation. J Bone Miner Res, 26:582. 2011.
70.
KathiresanS., VoightB.F., PurcellS., MusunuruK., ArdissinoD.et al.Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet, 41:334. 2009.
71.
ChuP.H., ChenJ.The novel roles of four and a half LIM proteins 1 and 2 in the cardiovascular system. Chang Gung Med J, 34:127. 2011.
72.
KwapiszewskaG., WygreckaM., MarshL.M., SchmittS., TrosserR.et al.Fhl-1, a new key protein in pulmonary hypertension. Circulation, 118:1183. 2008.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
